These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 7367833)

  • 21. Clonal proliferation of lymphoid and myeloid progenitor cells in patients with hematological abnormalities.
    Górski A; Rokicka-Milewska R; Litwin J; Kolakowska-Polubiec K; Madaliński K
    Vox Sang; 1979; 37(2):84-8. PubMed ID: 227173
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Weekly mitoxantrone therapy of Hodgkin's disease, non-Hodgkin's lymphoma, and chronic lymphocytic leukemia. A Southeastern Cancer Study Group Trial.
    Keller JW; Omura GA; Gams RA; Bartolucci AA
    Am J Clin Oncol; 1987 Jun; 10(3):194-5. PubMed ID: 3591737
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Cytochemical and immunologic characteristics of lymphocytes in lymphoproliferative diseases].
    Soboleva TN; Lukina EA; Mokeeva RA; Zhuravlev VS
    Lab Delo; 1984; (9):515-20. PubMed ID: 6210398
    [No Abstract]   [Full Text] [Related]  

  • 24. Serum immunoglobulins in leukaemia and malignant lymphoma.
    Solanki RL; Anand VK; Arora HL
    J Indian Med Assoc; 1990 Nov; 88(11):305-7. PubMed ID: 2086658
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Malignant lymphoma and lymphatic leukemia associated with myeloma-type serum proteins.
    AZAR HA; HILL WT; OSSERMAN EF
    Am J Med; 1957 Aug; 23(2):239-49. PubMed ID: 13444306
    [No Abstract]   [Full Text] [Related]  

  • 26. Cyclin D1 overexpression detected by a simple competitive reverse transcription-polymerase chain reaction assay for lymphoid malignancies.
    Taniguchi T; Fujita A; Takahashi S; Uchimaru K; Yoshikawa M; Asano S; Fujita T; Motokura T
    Jpn J Cancer Res; 1998 Feb; 89(2):159-66. PubMed ID: 9548443
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serum ferritin in hematologic malignancies.
    Matzner Y; Konijn AM; Hershko C
    Am J Hematol; 1980; 9(1):13-22. PubMed ID: 7001894
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CA 125 elevations in patients with malignant lymphomas.
    Fehm T; Beck E; Valerius T; Gramatzki M; Jäger W
    Tumour Biol; 1998; 19(4):283-9. PubMed ID: 9679739
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serum migration-inhibitory activity in patients with lymphoproliferative diseases.
    Cohen S; Fisher B; Yoshida T; Bettigole RE
    N Engl J Med; 1974 Apr; 290(16):882-6. PubMed ID: 4593612
    [No Abstract]   [Full Text] [Related]  

  • 30. Osmotic fragility of peripheral blood lymphocytes in some lymphoproliferative disorders.
    Karalias N; Inglessis N; Karabetsos Y; Kranidiotis A; Thomopoulos D
    Acta Haematol; 1984; 72(2):138-9. PubMed ID: 6437118
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Methylenetetrahydrofolate reductase C677T polymorphism in adult patients with lymphoproliferative disorders and its effect on chemotherapy.
    Timuragaoglu A; Dizlek S; Uysalgil N; Tosun O; Yamac K
    Ann Hematol; 2006 Dec; 85(12):863-8. PubMed ID: 16944145
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Monoclonal macroglobulinemia in malignant lymphoma.
    Moore DF; Migliore PJ; Shullenberger CC; Alexanian R
    Ann Intern Med; 1970 Jan; 72(1):43-7. PubMed ID: 4983128
    [No Abstract]   [Full Text] [Related]  

  • 33. [Beta 2-microglobulin in lymphoproliferative disorders].
    Leoni P; Sprovieri G; Recchioni A; Orrico C; Olivieri A
    G Clin Med; 1983; 64(9-10):315-25. PubMed ID: 6363188
    [No Abstract]   [Full Text] [Related]  

  • 34. Impaired phytohaemagglutinin-induced cytotoxicity in vitro of lymphocytes from patients with Hodgkin's disease or chronic lymphatic leukaemia.
    Holm G; Perlmann P; Johansson B
    Clin Exp Immunol; 1967 May; 2(3):351-60. PubMed ID: 6035198
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Familial Hodgkin's lymphoma in Scandinavia.
    Jønsson V; Awan H; Nyquist E; Maisenhølder M; Johannesen TB; Ly B; Tjønnfjord GE
    In Vivo; 2011; 25(3):431-7. PubMed ID: 21576419
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Usefulness of biologic tests in malignant hemopathies].
    Clément F
    Schweiz Med Wochenschr; 1983 Jul; 113(26):948-51. PubMed ID: 6612275
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reactivity of lymphocytes from primary neoplasms of lymphoid tissues.
    Twomey JJ; Laughter AH; Lazar S; Douglass CC
    Cancer; 1976 Aug; 38(2):740-7. PubMed ID: 135638
    [TBL] [Abstract][Full Text] [Related]  

  • 38. alpha-Naphthyl acetate esterase activity--a cytochemical marker for T lymphocytees. Correlation with immunologic studies of normal tissues, lymphocytic leukemias, non-Hodgkin's lymphomas, Hodgkin's disease, and other lymphoproliferative disorders.
    Pinkus GS; Hargreaves HK; McLeod JA; Nadler LM; Rosenthal DS; Said JW
    Am J Pathol; 1979 Oct; 97(1):17-41. PubMed ID: 315166
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Serum glycoproteins in malignant blood diseases].
    MIHAESCU C; MIHAESCU E; GROZEA P
    Stud Cercet Med Interna; 1961; 2():823-31. PubMed ID: 14473645
    [No Abstract]   [Full Text] [Related]  

  • 40. Lymphocytic characterization in Hodgkin's and non-Hodgkin's lymphoma.
    Kamthan M; Joshi N; Sharma ML
    Indian J Pathol Microbiol; 1982 Apr; 25(2):139-43. PubMed ID: 6982850
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.